Anna Villar‐Piqué

2.3k total citations
44 papers, 1.4k citations indexed

About

Anna Villar‐Piqué is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Anna Villar‐Piqué has authored 44 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 18 papers in Neurology and 18 papers in Physiology. Recurrent topics in Anna Villar‐Piqué's work include Prion Diseases and Protein Misfolding (23 papers), Alzheimer's disease research and treatments (16 papers) and Neurological diseases and metabolism (13 papers). Anna Villar‐Piqué is often cited by papers focused on Prion Diseases and Protein Misfolding (23 papers), Alzheimer's disease research and treatments (16 papers) and Neurological diseases and metabolism (13 papers). Anna Villar‐Piqué collaborates with scholars based in Spain, Germany and United Kingdom. Anna Villar‐Piqué's co-authors include Tiago F. Outeiro, Tomás Lopes da Fonseca, Salvador Ventura, Inga Zerr, Franc Llorens, Matthias Schmitz, Raimon Sabaté, Péter Hermann, Alba Espargaró and Daniela Varges and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Anna Villar‐Piqué

44 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Villar‐Piqué Spain 21 624 616 525 303 217 44 1.4k
Sangjune Kim South Korea 15 871 1.4× 602 1.0× 442 0.8× 288 1.0× 379 1.7× 37 1.6k
Abhisek Mukherjee United States 14 495 0.8× 683 1.1× 514 1.0× 264 0.9× 208 1.0× 25 1.4k
Mineo Yamazaki Japan 25 722 1.2× 572 0.9× 591 1.1× 364 1.2× 298 1.4× 87 1.7k
Rebecca L. Wallings United States 10 760 1.2× 421 0.7× 361 0.7× 389 1.3× 294 1.4× 19 1.3k
Amanda L. Woerman United States 17 988 1.6× 744 1.2× 757 1.4× 584 1.9× 376 1.7× 35 1.7k
Stella Gagliardi Italy 23 696 1.1× 833 1.4× 210 0.4× 237 0.8× 131 0.6× 78 1.6k
Luis Concha‐Marambio United States 16 487 0.8× 455 0.7× 276 0.5× 217 0.7× 107 0.5× 31 1.0k
Matthias Elstner Germany 17 421 0.7× 622 1.0× 199 0.4× 206 0.7× 294 1.4× 31 1.2k
Fabio Moda Italy 25 506 0.8× 1.3k 2.2× 594 1.1× 646 2.1× 224 1.0× 68 2.0k
Yinxia Chao Singapore 17 608 1.0× 542 0.9× 177 0.3× 338 1.1× 339 1.6× 33 1.4k

Countries citing papers authored by Anna Villar‐Piqué

Since Specialization
Citations

This map shows the geographic impact of Anna Villar‐Piqué's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Villar‐Piqué with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Villar‐Piqué more than expected).

Fields of papers citing papers by Anna Villar‐Piqué

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Villar‐Piqué. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Villar‐Piqué. The network helps show where Anna Villar‐Piqué may publish in the future.

Co-authorship network of co-authors of Anna Villar‐Piqué

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Villar‐Piqué. A scholar is included among the top collaborators of Anna Villar‐Piqué based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Villar‐Piqué. Anna Villar‐Piqué is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hermann, Péter, Isabel Schmidt, Stefan Goebel, et al.. (2023). Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer’s disease. Alzheimer s Research & Therapy. 15(1). 106–106. 5 indexed citations
2.
Schmitz, Matthias, Juan Carlos Espinosa, Natalia Fernández‐Borges, et al.. (2022). Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease. Molecular Neurobiology. 59(9). 1–9. 8 indexed citations
3.
Schmitz, Matthias, Anna Villar‐Piqué, Fabian Maass, et al.. (2021). Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies. Frontiers in Aging Neuroscience. 13. 717930–717930. 20 indexed citations
4.
Candelise, Niccolò, Matthias Schmitz, Katrin Thüne, et al.. (2020). Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays. Translational Neurodegeneration. 9(1). 5–5. 57 indexed citations
5.
Schmitz, Matthias, Niccolò Candelise, Ειrini Kanata, et al.. (2019). Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency. Molecular Neurobiology. 57(4). 1863–1874. 14 indexed citations
6.
Blennow, Kaj, Daniela Díaz‐Lucena, Henrik Zetterberg, et al.. (2019). CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD. Journal of Neurology Neurosurgery & Psychiatry. 90(8). 846–853. 52 indexed citations
7.
Villar‐Piqué, Anna, Matthias Schmitz, Péter Hermann, et al.. (2019). Plasma YKL-40 in the spectrum of neurodegenerative dementia. Journal of Neuroinflammation. 16(1). 145–145. 51 indexed citations
8.
Zerr, Inga, Anna Villar‐Piqué, Anna Poleggi, et al.. (2019). Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients. Biomolecules. 9(12). 800–800. 10 indexed citations
9.
Villar‐Piqué, Anna, Franc Llorens, & Inga Zerr. (2019). Cerebrospinal fluid neurogranin as a new player in prion disease diagnosis and prognosis. Neural Regeneration Research. 15(5). 861–861. 6 indexed citations
10.
Llorens, Franc, Anna Villar‐Piqué, Péter Hermann, et al.. (2019). Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt–Jakob disease: a comparative prospective study with 14-3-3. Journal of Neurology. 267(2). 543–550. 7 indexed citations
11.
Candelise, Niccolò, Matthias Schmitz, Franc Llorens, et al.. (2019). Seeding variability of different alpha synuclein strains in synucleinopathies. Annals of Neurology. 85(5). 691–703. 87 indexed citations
12.
Schmitz, Matthias, Anna Villar‐Piqué, Franc Llorens, et al.. (2018). Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy. Molecular Neurobiology. 56(5). 3476–3483. 23 indexed citations
13.
Villar‐Piqué, Anna, Matthias Schmitz, Niccolò Candelise, et al.. (2018). Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases. Molecular Neurobiology. 55(9). 7588–7605. 17 indexed citations
14.
Llorens, Franc, Angela da Silva Correia, Anna Villar‐Piqué, et al.. (2018). Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie. Molecular Neurobiology. 55(11). 8586–8591. 17 indexed citations
15.
Gerhardt, Ellen, Tomás Lopes da Fonseca, Anna Villar‐Piqué, et al.. (2018). Membrane binding, internalization, and sorting of alpha-synuclein in the cell. Acta Neuropathologica Communications. 6(1). 79–79. 75 indexed citations
16.
Gonçalves, S., Anna Villar‐Piqué, Patrícia Guerreiro, et al.. (2014). The small GTPase Rab11 co-localizes with  -synuclein in intracellular inclusions and modulates its aggregation, secretion and toxicity. Human Molecular Genetics. 23(25). 6732–6745. 73 indexed citations
17.
Villar‐Piqué, Anna, Alba Espargaró, Salvador Ventura, & Raimon Sabaté. (2014). Screening for Amyloid Aggregation: In-Silico, In-Vitro and In-Vivo Detection. Current Protein and Peptide Science. 15(5). 477–489. 10 indexed citations
18.
Navarro, Susanna, Anna Villar‐Piqué, & Salvador Ventura. (2014). Selection against toxic aggregation-prone protein sequences in bacteria. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(5). 866–874. 14 indexed citations
19.
Villar‐Piqué, Anna & Salvador Ventura. (2013). Protein aggregation propensity is a crucial determinant of intracellular inclusion formation and quality control degradation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(12). 2714–2724. 15 indexed citations
20.
Villar‐Piqué, Anna, Natalia Sánchez de Groot, Raimon Sabaté, et al.. (2011). The Effect of Amyloidogenic Peptides on Bacterial Aging Correlates with Their Intrinsic Aggregation Propensity. Journal of Molecular Biology. 421(2-3). 270–281. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sangjune Kim Breakdown of academic impact, for papers by Abhisek Mukherjee Breakdown of academic impact, for papers by Mineo Yamazaki Breakdown of academic impact, for papers by Rebecca L. Wallings Breakdown of academic impact, for papers by Amanda L. Woerman Breakdown of academic impact, for papers by Stella Gagliardi Breakdown of academic impact, for papers by Luis Concha‐Marambio Breakdown of academic impact, for papers by Matthias Elstner Breakdown of academic impact, for papers by Fabio Moda Breakdown of academic impact, for papers by Yinxia Chao
Rankless by CCL
2026